Hospital preparedness to bioterrorism and other infectious disease emergencies

Cellular and Molecular Life Sciences

Volumn 63, Issue 19-20, 2006, Pages 2213-2222

  Ippolito, G ^a   Puro, V ^a   Heptonstall, J ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SCARBOROUGH HOSPITAL   (United Kingdom)

Author keywords

Bioterrorism; Emerging infectious diseases; Hospital preparedness; Infection control

Indexed keywords

AWARENESS; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; DEVELOPING COUNTRY; DISEASE TRANSMISSION; EMERGENCY CARE; EPIDEMIC; HEALTH CARE; HEALTH EDUCATION; HEALTH PRACTITIONER; HOSPITAL CARE; HUMAN; INFECTION; INFECTION CONTROL; MASS COMMUNICATION; PATHOGENESIS; PUBLIC HEALTH; REVIEW; SALMONELLA ENTERITIDIS; SALMONELLA TYPHI; SEVERE ACUTE RESPIRATORY SYNDROME; SHIGELLA DYSENTERIAE; WORLD HEALTH ORGANIZATION;

BIOTERRORISM; COMMUNICABLE DISEASES; COMMUNICATION; DISEASE OUTBREAKS; EDUCATION, MEDICAL, CONTINUING; HOSPITALS; HUMANS; INFECTION CONTROL; OCCUPATIONAL HEALTH SERVICES;

EID: 33750485841     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6309-y     Document Type: Review

References (83)

1. Smolinski, M. S., Hamburg, M. A., Lederberg, J., editors. (2003) Microbial Threats to Health: Emergence, Detection, and Response. National Academy Press, Washington, DC.
2. Morens, D. M., Folkers, G. K. and Fauci, A. S. (2004) The challenge of emerging and re-emerging infectious diseases. Nature 430, 242-249.
3. Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., Hauer J, Layton, M., McDade, J., Osterholm, M. T. et al. (1999) Smallpox as a biological weapon; medical and public health management. Working Group on Civilian Biodefense. JAMA 281, 2127-2137.
4. Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Hauer, J., McDade, J., Osterholm, M. T., O'Toole et al. (1999) Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281, 1735-1745.
5. Centers for Disease Control and Prevention (2001) Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR 50, 889-893.
6. Centers for Disease Control and Prevention (2000) Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 49 (RR-4): 1-14.
7. World Health Organisation (2004) Public Health Response to Biological Weapons: WHO Guidance (2004), World Health Organisation, Geneva.
8. National Institute of Allergy and Infectious Diseases. National Biodefense Effort. Available at: http://www3.niaid.nih.gov/biodefense/about/nbe. htm (accessed May 23, 2006).
9. Anonymous (1966) Deliberate spreading of typhoid in Japan. Science 2, 11-12.
10. Torok, T. J., Tauxe, R. V., Wise, R. P., Livengood, J. R., Sokolow, R., Mauvais, S., Birkness, K. A., Skeels, M. R., Horan, J. M. and Foster, L. R. (1997) A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 278, 389-395.
11. Kolavic, S. A., Kimura, A., Simons, S. L., Slutsker, L., Barth, S. and Haley, C. E. (1997) An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. JAMA 278, 396-398.
12. Phills, J. A., Harrold, A. J., Whiteman, G. V. and Perelmutter, L. (1972) Pulmonary infiltrates, asthma and eosinophilia due to Ascaris suum infestation in man. N. Engl. J. Med. 286, 965-970.
13. Jernigan, J. A., Stephens, D. S., Ashford, D. A., Omenaca, C., Topiel, M. S., Galbraith, M., Tapper M, Fisk, T. L., Zaki, S., Popovic, T. et al. (2001) Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Inf. Dis. 7, 933-944.
14. Borio, L., Frank, D., Mani, V., Chiriboga, C., Pollanen, M., Ripple, M., Ali, S., DiAngelo, C., Lee, J., Arden, J. et al. (2001) Death due to bioterrorism-related anthrax; report of 2 patients. JAMA 286, 2554-2559.
15. Mayer, T. A., Bersoff-Matcha, S., Murphy, C., Earls, J., Harper, S., Pauze, D., Nguyen, M., Rosenthal, J., Cerva, D. Jr et al. (2001) Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA 286, 2549-2553.
16. Bush, L. M., Abrams, B. H., Beall, A. and Johnson, C. C. (2001) Index case of fatal inhalational anthrax due to bioterrorism in the United States. N. Engl. J. Med. 50, 973-976.
17. Mina, B., Dym, J. P., Kuepper, F., Tso, R., Arrastia, C., Kaplounova, I., Faraj, H., Kwapniewski, A., Krol, C. M., Grosser, M. et al. (2002) Fatal inhalational anthrax with unknown source of exposure in a 61-year old woman in New York City. JAMA 287, 858-862.
18. Freedman, A., Afonja, O., Chang, M. W., Mostashari, F., Blaser, M., Perez-Perez, G., Lazarus, H., Schacht, R., Guttenberg, J., Traister, M. and Borkowsky, W. (2002) Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month old infant. JAMA 287, 869-874.
19. Barakat, L. A., Quentzel, H. L., Jernigan, J. A., Kirschke, D. L., Griffith, K., Spear, S. M., Kelley, K., Barden, D., Mayo, D., Stephens, D. S. et al. (2002) Fatal inhalational anthrax in a 94-year old Connecticut woman. JAMA 287, 863-868.
20. Jernigan, D. B., Raghunathan, P. L., Bell, B. P., Brechner, R., Bresnitz, E. A., Butler, J. C., Cetron, M., Cohen, M., Doyle, T., Fischer, M. et al. (2002) Investigation of bioterrorism-related anthrax, United States, 2001, epidemiologic findings. Emerg. Inf. Dis. 8, 1019-1028.
21. Centers for Disease Control and Prevention (2001) Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 50, 909-919.
22. Hughes, J. M. and Gerberding, J. L. (2002) Anthrax bioterrorism: lessons learned and future directions. Emerg. Inf. Dis. 8, 1013-1014.
23. World Health Organisation (2004) Laboratory Biosafety Manual, 3rd edn. World Health Organisation, Geneva (WHO/CDS/CSR/LYO/2004.11).
24. Federal Register, DHHS (2003) 42 CFR Part 73. Possession, use, and transfer of select agents and toxins. Fed. Regist. 2003; 68 (212): 62245-62247.
25. Centers for Disease Control and Prevention, Richmond J. Y. and Nesby-O'Dell, S. L. (2002) Laboratory security and emergency response guidance for laboratories working with select agents. MMWR 51 (RR19): 1-8.
26. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Based on data as of 31 December 2003. Available at: http://www.who.int/csr/sars/country/table2004_04_21/en/ index.html (accessed May 23, 2006).
27. Svoboda, T., Henry, B., Shulman, L., Kennedy, E., Rea, E., Ng, W., Wallington, T., Yaffe, B., Gournis, E., Vicencio, E., Basrur, S. and Glazier, R. H. (2004) Public health measures to control the spread of severe acute respiratory syndrome during the outbreak in Toronto. N. Engl. J. Med. 350, 2352-2361.
28. National Advisory Committee on SARS and Public Health (2003) Learning from SARS: renewal of public health in Canada. Health Canada. Ottawa, Canada.
29. Centers for Disease Control and Prevention (2003) Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin, 2003. MMWR 52, 537-40.
30. Reed, K. D., Melski, J. W., Graham, M. B., Regnery, R. L., Sotir, M. J., Wegner, M. V., Kazmierczak, J. J., Stratman, E. J., Li, Y., Fairley, J. A. et al. (2004) The detection of monkeypox in humans in the western hemisphere. N. Engl. J. Med. 350, 342-350.
31. Centers for Disease Control and Prevention (2005) Outbreak of Marburg virus hemorrhagic fever-Angola, October 1, 2004-March 29, 2005. MMWR 54, 308-309.
32. EUNID archive of national guidelines on management of highly infectious diseases, 2005. Available at: http://www.eunid.com/index.asp (accessed May 23, 2006).
33. Advisory Committee on Dangerous Pathogens (1996) Management and Control of Viral Haemorrhagic Fevers. The Stationery Office, London.
34. Pourrut, X., Kumulungui, B., Wittmann, T., Moussavou, G., Delicat, A., Yaba, P., Nkoghe, D., Gonzalez, J. P. and Leroy, E. M. (2005) The natural history of Ebola virus in Africa. Microbes Infection 7, 1005-1014.
35. Peters, C. J. (2005) Marburg and Ebola-arming ourselves against the deadly filoviruses. N. Engl. J. Med. 352, 2571-3.
36. Crowcroft, N. S. (2002) Management of Lassa fever in European Countries. European Meeting Report. Eurosurveillance 7, 50-52.
37. Masuda, G. (1997) Viral haemorrhagic fevers (article in Japanese; abstract in English). Rinsho Byori 45, 751-756.
38. Macher, A. M., Wolfe, M. S. (2006) Historical Lassa fever reports and 30-year clinical update. Emerg. Inf. Dis. 12, 835-837.
39. Isaacson, M. (2001) Viral haemorrhagic fever hazards for travelers in Africa. Clin. Infect Dis. 33, 1707-1712.
40. Borio, L., Inglesby, T. V., Peters, C. J., Schmaljohn, A. L., Hughes, J. M., Jahrling, P. B., Ksiazek, T., Johnson, K. M., Meyerhoff, A., O'Toole, T., Ascher, M. S. et al. (2002) Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287, 2391-2405.
41. Centers for Disease Control and Prevention (1995) Management of patients with suspected viral hemorrhagic fever - United States. MMWR 44, 475-479.
42. Ippolito, G., Nicastri, E., Capobianchi, M., Di Caro, A., Petrosillo, N. and Puro, V. (2005) Hospital preparedness and management of patients affected by viral haemorrhagic fever or smallpox at the Lazzaro Spallanzani Institute, Italy. Euro. Surveill. 10, 36-39.
43. Centers for Disease Control and Prevention (2000) Laboratory-acquired human glanders - Maryland, May 2000. MMWR 49, 532-535.
44. Moussatche, N., Tuyama, M., Kato, S. E., Castro, A. P., Njaine, B., Peralta, R. H., Peralta, J. M., Damaso, C. R. and Barroso, P. F. (2003) Accidental infection of laboratory worker with vaccinia. Emerg. Inf. Dis. 9, 724-726.
45. Mempel, M., Isa, G., Klugbauer, N., Meyer, H., Wildi, G., Ring, J., Hofmann, F. and Hofmann, H. (2003) Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct. J. Invest. Dermatol. 120, 356-358.
46. Loeb, M., Zando, I., Orvidas, M. C., Bialachowski, A., Groves, D. and Mahoney, J. (2003) Laboratory-acquired vaccinia infection. Can. Commun. Dis. Rep. 29, 134-136.
47. Wldodaver, C. V., Palumbo, G. J. and Waner, J. L. (2004) Laboratory-acquired vaccinia infection. J. Clin. Virol. 29, 167-170.
48. Health and Safety Executive. Incidents - lessons to be learnt. Accidental infection with vaccinia virus. ACGM Newsletter No. 32, June 2003. Available at: http://www.hse.gov.uk/biosafety/gmo/acgm/acgm32/paper8.htm (accessed May 23, 2006).
49. Barry, M. A. Report of pneumonic tularemia in three Boston University researchers, November 2004 - March 2005. Boston Public Health Commission, Boston, March 28, 2005. Available at: http://www.bphc.org/reports/pdfs/ report_202.pdf (accessed May 23, 2006).
50. Lim, P. L., Kurup, A. and Gopalakrishna, G. (2004) Laboratory-acquired severe acute respiratory syndrome. N. Engl. J. Med. 350, 1740-5.
51. World Health Organisation. Severe acute respiratory syndrome (SARS) in Taiwan, China. 17 December 2003. Available at: http://www.who.int/csr/don/ 2003_12_17/en/index.html (accessed May 23, 2006).
52. World Health Organisation. China's latest SARS outbreak has been contained, but biosafety concerns remain - Update 7. 18 May 2004. Available at: http://www.who.int/csr/don/2004_05_ 18a/en/index.html (accessed May 23, 2006).
53. Pro-Med Mail. PRO/AH〉 Ebola, lab accident death-Russia (Siberia) (04), 23 August 2004. Archive number 20040823.2350. Available at: http://www.promedmail.org/pls/askus/f?p=2400 :1202:3770738951369366471::NO:: F2400_P1202_CHECK_ DISPLAY,F2400_P1202_PUB_MAIL_ID:X,26482 (accessed May 23, 2006).
54. Centers for Disease Control and Prevention (2002) Update: cutaneous anthrax in a laboratory worker - Texas, 2002. MMWR 51, 482.
55. Noviello, S., Gallo, R., Kelly, M., Limberger, R. J., DeAngelis, K., Cain, L., Wallace, B. and Dumas, N. (2004) Laboratory-acquired brucellosis. Emerg. Inf. Dis. 10, 1048-1050.
56. Centers for Disease Control and Prevention (2002) Laboratory-acquired West Nile virus infections - United States, 2002. MMWR 51, 1133-1135.
57. World Health Organisation. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO - 12 May 2006. Available at: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2006_05_12/ en/index.html (accessed May 23, 2006).
58. Ungchusak, K., Auewarakul, P., Dowell, S. F., Kitphati, R., Auwanit, W., Puthavathana, P., Uiprasertkul, M., Boonnak, K., Pittayawonganon, C., Cox, N. J. et al. (2005) Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352, 333-340.
59. World Health Organisation. Current WHO phase of pandemic alert, November 2005. Available at: http://www.who.int/csr/disease/avian_influenza/phase/en/ index.html (accessed May 23, 2006).
60. World Health Organisation. WHO global influenza preparedness plan. The role of WHO and recommendations for national measures before and during pandemics. March 2005. WHO/ CDS/CSR/GIP/2005.5. Available at: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_ 2005_5/en/index.html (accessed May 23, 2006).
61. Health Protection Agency. Influenza pandemic planning and guidance. Available at: http://www.hpa.org.uk/infections/topics_az/influenza/pandemic/ guideline.htm#clinical (accessed May 23, 2006).
62. Health Protection Agency. Avian influenza. Available at: http:// www.hpa.org.uk/infections/topics_az/influenza/avian/default. htm (accessed May 23, 2006).
63. Mounier-Jack, S. and Coker, R. J. (2006) How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet 367, 1405-1411.
64. Nicoll, A. and Kaiser, R. (2006) Limitations of recently published review of national influenza pandemic plans in Europe. Euro Surveill. Weekly 11, E060427.3. Available at: http://www. eurosurveillance.org/ew/2006/060427.asp#3 (accessed May 23, 2006).
65. Toner, E., Waldhorn, R., Maldin, B., Borio, L., Nuzzo, J. B. Lam, C., Franco, C., Henderson, D. A., Inglesby, T. V. and O'Toole, T. (2006) Meeting report: hospital preparedness for pandemic influenza. Biosecur. Bioterror 4, 1-11.
66. Petrosillo, N., Puro, V., Di Caro, A. and Ippolito, G. (2005) The initial hospital response to an epidemic. Arch. Med. Res. 36, 706-712.
67. Madoff, L. C. and Woodall, J. P. (2005) The internet and the global monitoring of emerging diseases: lessons from the first 10 years of ProMED-mail. Arch. Med. Res. 36, 724-730.
68. Heymann, D. L. and Rodier, G. R., WHO Operational Support Team to the Global Outbreak Alert and Response Network (2001) Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet Inf. Dis. 1, 345-353.
69. Heptonstall, J. and Gent, N. (2005) CBRN Incidents: Clinical management and Health Protection. Health Protection Agency, London. Available at: http://www.hpa.org.uk/emergency/CBRN.htm (accessed May 23, 2006).
70. Seward, J. F., Galil, K., Damon, I., Norton, S. A., Rotz, L., Schmid, S., Harpaz, R., Cono, J., Marin, M., Hutchins, S., Chaves, S. S. and McCauley, M. M. (2004) Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002-2004. Clin. Infect Dis. 39, 1477-1483.
71. Health Protection Agency. Algorithm for the management of returning travellers from countries affected by SARS, presenting with febrile respiratory illness. Available at: http:// www.hpa.org.uk/infections/topics_az/SARS/ Guidelines.htm (accessed May 23, 2006).
72. Centers for Infectious Disease Research and Policy (CIDRAP). Clinical pathway: viral haemorrhagic fever. Available at: http:// www.cidrap.umn.edu/ cidrap/files/25/vhf_clinical_pathway.pdf (accessed May 23, 2006).
73. Garner, J. S. (1996) Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect. Control. Hosp. Epidemiol. 17, 53-80.
74. Centers for Disease Control and Prevention. Respiratory hygiene/cough etiquette in healthcare settings. Available at: http:// www.cdc.gov/flu/ professionals/infectioncontrol/resphygiene.htm (accessed May 23, 2006).
75. World Health Organisation (2006) Avian influenza, including influenza A (H5N1), in humans: WHO interim infection control guideline for health care facilities. Revised 24 April 2006. Available at: http://www.who.int/csr/disease/ avian_influenza/guidelines/infectioncontrol1/en/index.html (accessed May 23, 2006).
76. Klein, K. R., Rosenthal, M. S. and Klausner, H. A. (2005) Blackout 2003: preparedness and lessons learned from the perspectives of four hospitals. Prehospital Disaster Med. 20, 343-349.
77. Shapiro, D. S. (2003) Surge capacity for response to bioterrorism in hospital clinical microbiology laboratories. J. Clin. Microbiol. 41, 5372-5376.
78. Centers for Disease Control and Prevention. FluSurge2.0 Software. Available at: http://www.cdc.gov/flu/flusurge.htm (accessed May 23, 2006).
79. World Health Organisation (2005) Outbreak communication guidelines. WHO/CDS/2005.28, WHO, Geneva, 2005. Available at: http://www.who.int/infectious- disease-news/IDdocs/ whocds200528/whocds200528en.pdf.
80. World Health Organisation (2005) Effective media communication during public health emergencies. WHO Handbook and Field Guide. WHO, Geneva. Available at: http://www.who. int/csr/resources/publications/WHO_CDS_2005_31/en/index.html (accessed May 23, 2006).
81. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). Updated recommendations, October 2004. Available at: http://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1/en/index. html (accessed May 23, 2006).
82. Rusnak, J. M., Kortepeter, M. G., Hawley, R. J., Boudreau, E., Aldis, J. and Pittman, P. R. (2004) Management guidelines for laboratory exposures to agents of bioterrorism. J. Occ. Environ. Med. 46, 791-800.
83. Centers for Disease Control and Prevention. Emergency Preparedness and Response. Disaster Mental Health Resources. Available at: http://www.bt.cdc.gov/ mentalhealth/ (accessed May 23, 2006).